Skip to main navigation
Skip to search
Skip to main content
Bar-Ilan University Home
Help & FAQ
Home
Researchers
Organisations
Research output
Prizes
Student theses
Courses
Activities
Projects
Press/Media
Datasets
Equipment
Search by expertise, name or affiliation
Treating heart failure with sildenafil
Arnon Blum
Poriya Medical Center
Research output
:
Contribution to journal
›
Review article
›
peer-review
17
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Treating heart failure with sildenafil'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Heart Failure
100%
Sildenafil
100%
Quality of Life
33%
Hydrolysis
33%
Patients with Heart Failure
33%
Phosphodiesterase
33%
Selective Inhibitor
33%
Pulmonary Hypertension
33%
Maximal Oxygen Uptake
33%
Exercise Capacity
33%
Cyclic GMP
33%
Systolic Heart Failure
33%
Ventilation
33%
Heart Failure Management
33%
CO2 Output
33%
Selective Pulmonary Vasodilator
33%
5′-Phosphodiesterase
33%
Minute Ventilation
33%
Maximal Dilatation
33%
Endothelial Activation
33%
Ventilation Efficiency
33%
Secondary Pulmonary Hypertension
33%
Muscle Perfusion
33%
Pulmonary Vasculature
33%
Breathlessness
33%
Therapeutic Management
33%
Ergoreflex
33%
Output Curve
33%
Exercise Efficiency
33%
Medicine and Dentistry
Heart Failure
100%
Sildenafil
100%
Pulmonary Hypertension
66%
Exercise
33%
Carbon Dioxide
33%
Phosphodiesterase V
33%
Dyspnea
33%
Oxygen Consumption
33%
Quality of Life
33%
Systolic Heart Failure
33%
Cyclic GMP
33%
Muscle Perfusion
33%
Pulmonary Vasculature
33%
Phosphodiesterase
33%
Respiratory Minute Volume
33%
Therapeutic Management
33%
Peripheral Vasodilating Agent
33%
Pharmacology, Toxicology and Pharmaceutical Science
Sildenafil
100%
Heart Failure
100%
Pulmonary Hypertension
66%
Carbon Dioxide
33%
Phosphodiesterase V
33%
Phosphodiesterase
33%
Systolic Heart Failure
33%
Peripheral Vasodilating Agent
33%
Cyclic GMP
33%
Dyspnea
33%